Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
73,943,049
-
Total 13F shares
-
38,531,736
-
Share change
-
+38,503,012
-
Total reported value
-
$384,149,816
-
Price per share
-
$9.97
-
Number of holders
-
102
-
Value change
-
+$383,863,185
-
Number of buys
-
100
Institutional Holders of Perspective Therapeutics, Inc. - COMMON STOCK (CATX) as of Q2 2024
As of 30 Jun 2024,
Perspective Therapeutics, Inc. - COMMON STOCK (CATX) was held by
102 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
38,531,736 shares.
The largest 10 holders included
COMMODORE CAPITAL LP, JANUS HENDERSON GROUP PLC, BlackRock Inc., Avidity Partners Management LP, VANGUARD GROUP INC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Octagon Capital Advisors LP, MARSHALL WACE, LLP, GEODE CAPITAL MANAGEMENT, LLC, and STATE STREET CORP.
This page lists
102
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.